HARBOUR BIOMED
Summary
Harbour BioMed is a global clinical-stage biopharmaceutical company discovering, developing and commercializing novel antibody therapeutics in immunology and oncology.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 81 M
Avg. Deal Size£ 81 M
All rights reserved. Copyright © 2025 Datasite
